Science Explorer Back to mapMap
Discussion
Researcher · Klinik Schillerhöhe · Germany

Martin Kimmich

Martin Kimmich publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment and Lung Cancer Research Studies.

ORCID 0000-0003-4936-0333 OpenAlex
World rank
#2,968,915
of 7,710,434 ranked researchers
Rank in Germany
#147,590
of 364,343
Works
60
Citations
1.5k
Citations per work
25.5
h-index
12
i10-index 16Top 42% in Pulmonary and Respiratory Medicine
Martin Kimmich

What does Martin Kimmich research?

Martin Kimmich's work is mostly in Medicine (75%), Biochemistry, Genetics and Molecular Biology (9%).

Health Sciences: 45 works · 74.6% of their workMedicine: 45 works · 74.6% of their workPulmonary and Respiratory Medicine: 26 works · 44.1% of their workOncology: 15 works · 24.9% of their workEpidemiology: 2 works · 2.8% of their workSurgery: 2 works · 2.8% of their workEverything else: 10 works · 16.4% of their workLife Sciences: 5 works · 9.0% of their workBiochemistry, Genetics and Molecular Biology: 5 works · 9.0% of their workMolecular Biology: 4 works · 6.2% of their workCancer Research: 2 works · 2.8% of their workTHEIR WORKMartin Kimmich60works
Life Sciences9%Health Sciences75%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine4574.6%
  2. Everything else1016.4%
    1. Biochemistry, Genetics and Molecular Biology59.0%
  1. 1Pulmonary and Respiratory Medicine44% of their works
  2. 2Oncology25% of their works
  3. 3Molecular Biology6% of their works
  4. 4Epidemiology3% of their works
  5. 5Cancer Research3% of their works
  6. 6Surgery3% of their works

Research topics

Which keywords describe Martin Kimmich's research?

The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Chemotherapy, ALK Inhibitors, EGFR Mutations, Immunotherapy, CT Screening and Lung Cancer.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Targeted Therapy463 topics
  2. Clinical Trials422 topics
  3. Chemotherapy292 topics
  4. ALK Inhibitors281 topic
  5. EGFR Mutations281 topic
  6. Immunotherapy232 topics
  7. CT Screening151 topic
  8. Lung Cancer151 topic
  9. Genomic Profiles141 topic
  10. Small-Cell Lung Cancer141 topic
  11. Immune Checkpoint Blockade131 topic
  12. PD-1 and PD-L1131 topic
  13. BAP1 mutations91 topic
  14. Malignant Pleural Mesothelioma91 topic
  15. Empyema81 topic
  16. Pleural Effusion81 topic
  17. Pulmonary Alveolar Microlithiasis51 topic
  18. Pulmonary Sclerosing Hemangioma51 topic
  19. Cancer Genomics41 topic
  20. Mutational Signatures41 topic

Where does Martin Kimmich work?

Martin Kimmich's main affiliation in the publication record is Klinik Schillerhöhe, Germany.

How many publications and citations does Martin Kimmich have?

OpenAlex counts 60 works and 1,527 citations for Martin Kimmich, an h-index of 12, ranking #2,968,915 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Martin Kimmich. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.